ストックスクリーナーアプリを入手
10.32
7.95%
0.76
アフターアワーズ：
10.47
0.15
+1.45%
前日終値:
$9.56
開ける：
$9.56
24時間の取引高:
1.12M
Relative Volume:
1.43
時価総額：
$547.08M
収益：
-
当期純損益:
$-29.44M
株価収益率:
-11.59
EPS:
-0.8906
ネットキャッシュフロー:
$-24.66M
1週間 パフォーマンス:
+19.58%
1か月 パフォーマンス:
+20.14%
6か月 パフォーマンス:
+240.59%
1年 パフォーマンス:
+429.23%
1日の値動き範囲:
$9.36
$10.38
1週間の範囲:
$8.57
$10.38
52週間の値動き範囲:
$1.87
$11.61
Immix Biopharma Inc Stock (IMMX) Company Profile
名前
Immix Biopharma Inc
セクター
電話
(888) 958-1084
住所
11400 WEST OLYMPIC BLVD., LOS ANGELES
Compare IMMX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMMX
Immix Biopharma Inc
|
10.32 | 506.80M | 0 | -29.44M | -24.66M | -0.8906 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immix Biopharma Inc Stock (IMMX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-25 | 開始されました | Morgan Stanley | Overweight |
| 2026-03-09 | 開始されました | Citizens | Mkt Outperform |
| 2026-02-09 | 開始されました | Mizuho | Outperform |
Immix Biopharma Inc (IMMX) 最新ニュース
Immix Biopharma, Inc.Common Stock (NQ: IMMX - FinancialContent
Immix Biopharma Finishes NEXICART-2 Trial Enrollment for Amyloidosis - HarianBasis.co
Is Immix Biopharma (IMMX) One of the Best Performing NASDAQ Stocks? - Insider Monkey
We Think Immix Biopharma (NASDAQ:IMMX) Can Afford To Drive Business Growth - Yahoo Finance
5 Best Performing NASDAQ Stocks According to Wall Street Analysts - Insider Monkey
[SCHEDULE 13G/A] Immix Biopharma, Inc. Amended Passive Investment Disclosure - Stock Titan
IMMX SEC FilingsImmix Biopharma Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Immix rises as Morgan Stanley starts with bullish view on CAR-T therapy - MSN
Immix Biopharma, Inc. (NASDAQ:IMMX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Immix Biopharma (IMMX) price target increased by 11.73% to 18.62 - MSN
IMMX (Immix Biopharma Inc.) posts wider Q4 2025 EPS miss, shares edge higher as investors focus on long-term pipeline.Retail Trader Ideas - Cổng thông tin điện tử tỉnh Lào Cai
IMMX Immix Biopharma Inc. posts wider Q4 2025 loss than expected as its shares gain nearly four percent on positive investor sentiment.Profit Announcement - Cổng thông tin điện tử tỉnh Tây Ninh
Immix Biopharma (IMMX) price target increased by 50.00% to 12.24 - MSN
HC Wainwright & Co. maintains Immix Biopharma (IMMX) buy recommendation - MSN
IMMX Immix Biopharma posts wider than expected Q4 2025 loss, shares edge lower on investor disappointment.Community Trade Ideas - Newser
Immix Biopharma (NASDAQ:IMMX) Trading Down 4.6%Time to Sell? - MarketBeat
We're Hopeful That Immix Biopharma (NASDAQ:IMMX) Will Use Its Cash Wisely - 富途牛牛
Moving Averages: Should I trade or invest in Immix Biopharma IncWall Street Watch & Precise Swing Trade Alerts - baoquankhu1.vn
IMMX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Bear Alert: Is Immix Biopharma Inc in a bullish channel2026 Analyst Calls & Weekly High Conviction Ideas - baoquankhu1.vn
Guidance Update: Is Immix Biopharma Inc stock a buy or sell2026 Bull vs Bear & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Does inflation impact Immix Biopharma (IMMX) Stock | Price at $9.19, Down 5.79%Most Watched Stocks - Newser
Immix Biopharma to Participate in Jefferies Global Healthcare Conference - National Today
Immix Biopharma to Host Investor Meetings at Jefferies Global Healthcare Conference 2026 - Quiver Quantitative
Immix Biopharma to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire
Immix Biopharma lines up investor meetings at Jefferies event - Stock Titan
Is Immix Biopharma (IMMX) Stock Ready to Move | Price at $9.09, Up 5.82%Stock Surge - Xã Thanh Hà
Immix Biopharma (IMMX) seeks approval of board slate, auditor and reviews 2025 executive pay - Stock Titan
Earnings Recap: Is Immix Biopharma Inc benefiting from innovation trendsNew Guidance & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Is Immix Biopharma (IMMX) Stock showing reversal signs | Price at $9.26, Down 5.03%Top Analyst Picks - Cổng thông tin điện tử Tỉnh Sơn La
Immix Biopharma, Inc. (NASDAQ:IMMX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Immix Biopharma Stock Price Forecast. Should You Buy IMMX? - stockinvest.us
Citizens Initiates Coverage of Immix Biopharma (IMMX) with Market Outperform Recommendation - MSN
IMMX PE Ratio & Valuation, Is IMMX Overvalued - Intellectia AI
Immix Biopharma ― NEXICART-2 の進展で勢いが増す - Smartkarma
Weekly Earnings: Is Immix Biopharma Inc stock a buy or sell2026 Chart Watch & Daily Entry Point Alerts - baoquankhu1.vn
Bear Alert: Is Immix Biopharma Inc benefiting from innovation trends2026 WrapUp & Smart Swing Trading Techniques - baoquankhu1.vn
Citizens reiterates Immix Biopharma stock rating on trial enrollment By Investing.com - Investing.com South Africa
Citizens reiterates Immix Biopharma stock rating on trial enrollment - Investing.com
Immix Biopharma completes enrollment in AL amyloidosis trial By Investing.com - Investing.com South Africa
Immix Biopharma Inc (IMMX) 財務データ
収益
当期純利益
現金流量
EPS
1.77%
0.25%
大文字化:
|
ボリューム (24 時間):